tetrahydrocortisol has been researched along with Chronic Kidney Diseases in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aldosterone has emerged as an important mediator of disease progression and mortality in patients with chronic heart and kidney disease (CKD)." | 2.75 | The effect of spironolactone upon corticosteroid hormone metabolism in patients with early stage chronic kidney disease. ( Edwards, NC; Ferro, CJ; Hammer, F; Hughes, BA; Steeds, RP; Stewart, PM; Townend, JN, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hammer, F | 1 |
| Edwards, NC | 1 |
| Hughes, BA | 1 |
| Steeds, RP | 1 |
| Ferro, CJ | 1 |
| Townend, JN | 1 |
| Stewart, PM | 1 |
| Mongia, A | 1 |
| Vecker, R | 1 |
| George, M | 1 |
| Pandey, A | 1 |
| Tawadrous, H | 1 |
| Schoeneman, M | 1 |
| Muneyyirci-Delale, O | 1 |
| Nacharaju, V | 1 |
| Ten, S | 1 |
| Bhangoo, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Is Spironolactone Safe and Effective in the Treatment of Cardiovascular Disease in Mild Chronic Renal Failure?[NCT00291720] | Phase 2 | 120 participants (Actual) | Interventional | 2005-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for tetrahydrocortisol and Chronic Kidney Diseases
| Article | Year |
|---|---|
The effect of spironolactone upon corticosteroid hormone metabolism in patients with early stage chronic kidney disease.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aldosterone; Angiotensin II; Blood Pressure; Female; Humans; H | 2010 |
1 other study available for tetrahydrocortisol and Chronic Kidney Diseases
| Article | Year |
|---|---|
Role of 11βHSD type 2 enzyme activity in essential hypertension and children with chronic kidney disease (CKD).
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Adolescent; Child; Child, Preschool; Female; Glomerular | 2012 |